Drug · DIN 02464616
FIBRYGA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 8, 2018; first marketed August 8, 2018.
- Drug Identification Number (DIN)
- 02464616
- Company (DIN owner)
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Fibrinogen, human B02BB01
- Class
- Human
- Record last updated
- February 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FIBRINOGEN (HUMAN) | 1 G | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 10, 2017: NOC 19903Supplement to a New Drug Submission (SNDS) · Product name change
- June 7, 2017: NOC 19383New Drug Submission (NDS)
Other DINs named FIBRYGA
- DIN 02565099 · Approved